Preclinical models demonstrate RAS(ON) multi-selective inhibition and combination therapies minimally affect body weight.
Supplementary Figure S10: RAS(ON) multi-selective inhibition with combination therapies have minimal effect on body weight
No takes yet. Share an insight, caveat, or question.
Orlen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: